1244 Polarized immune responses reveal actionable therapeutic targets in cutaneous adverse events to checkpoint inhibitors

• Mario E Lacouture,
• Neil J Shah,
• Lukas kraehenbuehl,
• Stephanie Gu,
• Andrea P Moy,
• Elena Goleva,
• Kwami Ketosugbo,
• Tara Maier,
• Trina Salvador,
• Ryan Weight,
• Veronica Rotemberg,
• Jeffrey A Kern,
• Donald Y Leung

Affiliations

Mario E Lacouture

Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Neil J Shah

Department of Medicine, Weill Cornell Medical College, New York, NY, USA

Lukas kraehenbuehl

1Memorial Sloan Kettering Cancer Center, New York, NY, USA

Stephanie Gu

1New York, NY, USA

Andrea P Moy

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Elena Goleva

2National Jewish Health, Denver, CO, USA

Kwami Ketosugbo

3Memorial Sloan Kettering Cancer Center, New York, NY, USA

Tara Maier

3Memorial Sloan Kettering Cancer Center, New York, NY, USA

Trina Salvador

3Memorial Sloan Kettering Cancer Center, New York, NY, USA

Ryan Weight

6The Skin Cancer Institute, Denver, CO, USA

Veronica Rotemberg

3Memorial Sloan Kettering Cancer Center, New York, NY, USA

Jeffrey A Kern

2National Jewish Health, Denver, CO, USA

Donald Y Leung

2National Jewish Health, Denver, CO, USA